Strength in Mass Spec Leads Wells Fargo to Upgrades Thermo Fisher Scientific (TMO) to Outperform

Wells Fargo upgraded Thermo Fisher Scientific (NYSE: TMO) from Market Perform to Outperform with a price target of $72.50 (from $57.50).

Analysts are bullish on Thermo Fisher Scientific, especially considering its strength in the mass spectrometry.

"Our industry checks lead us to believe that TMO is taking share in the roughly $600 million high-end portion of the mass spec market", said Tim Evans. He is very optimistic about TMO's positioning, particularly at the high end.

For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more ratings news on Thermo Fisher Scientific click here.

Shares of Thermo Fisher Scientific closed at $60.30 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Freedom Broker Upgrades Serve Robotics (SERV) to Buy
• Freedom Broker Upgrades Lifeway Foods (LWAY) to Buy